Literature DB >> 21824773

1,6-Disubstituted indole derivatives as selective human neuronal nitric oxide synthase inhibitors.

Shawn Maddaford1, Paul Renton, Joanne Speed, Subhash C Annedi, Jailall Ramnauth, Suman Rakhit, John Andrews, Gabriela Mladenova, Lisa Majuta, Frank Porreca.   

Abstract

A series of 1,6-disubstituted indole derivatives was designed, synthesized and evaluated as inhibitors of human nitric oxide synthase (NOS). By varying the basic amine side chain at the 1-position of the indole ring, several potent and selective inhibitors of human neuronal NOS were identified. In general compounds with bulkier side chains displayed increased selectivity for nNOS over eNOS and iNOS isoforms. One of the compounds, (R)-8 was shown to reduce tactile hyperesthesia (allodynia) after oral administration (30 mg/kg) in an in vivo rat model of dural inflammation relevant to migraine pain.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21824773      PMCID: PMC5699210          DOI: 10.1016/j.bmcl.2011.07.042

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  17 in total

Review 1.  Blocking NO synthesis: how, where and why?

Authors:  Patrick Vallance; James Leiper
Journal:  Nat Rev Drug Discov       Date:  2002-12       Impact factor: 84.694

Review 2.  Selective neuronal nitric oxide synthase inhibitors.

Authors:  Erik P Erdal; Elizabeth A Litzinger; Jiwon Seo; Yaoqiu Zhu; Haitao Ji; Richard B Silverman
Journal:  Curr Top Med Chem       Date:  2005       Impact factor: 3.295

3.  Identification and initial structure-activity relationships of a novel non-peptide quinolone GnRH receptor antagonist.

Authors:  R J DeVita; D D Hollings; M T Goulet; M J Wyvratt; M H Fisher; J L Lo; Y T Yang; K Cheng; R G Smith
Journal:  Bioorg Med Chem Lett       Date:  1999-09-06       Impact factor: 2.823

4.  Crystal structures of zinc-free and -bound heme domain of human inducible nitric-oxide synthase. Implications for dimer stability and comparison with endothelial nitric-oxide synthase.

Authors:  H Li; C S Raman; C B Glaser; E Blasko; T A Young; J F Parkinson; M Whitlow; T L Poulos
Journal:  J Biol Chem       Date:  1999-07-23       Impact factor: 5.157

5.  Structural characterization of nitric oxide synthase isoforms reveals striking active-site conservation.

Authors:  T O Fischmann; A Hruza; X D Niu; J D Fossetta; C A Lunn; E Dolphin; A J Prongay; P Reichert; D J Lundell; S K Narula; P C Weber
Journal:  Nat Struct Biol       Date:  1999-03

6.  The structure of nitric oxide synthase oxygenase domain and inhibitor complexes.

Authors:  B R Crane; A S Arvai; R Gachhui; C Wu; D K Ghosh; E D Getzoff; D J Stuehr; J A Tainer
Journal:  Science       Date:  1997-10-17       Impact factor: 47.728

7.  Chronic inhibition of nitric oxide production accelerates neointima formation and impairs endothelial function in hypercholesterolemic rabbits.

Authors:  A J Cayatte; J J Palacino; K Horten; R A Cohen
Journal:  Arterioscler Thromb       Date:  1994-05

Review 8.  Design of selective neuronal nitric oxide synthase inhibitors for the prevention and treatment of neurodegenerative diseases.

Authors:  Richard B Silverman
Journal:  Acc Chem Res       Date:  2009-03-17       Impact factor: 22.384

9.  N-Phenylamidines as selective inhibitors of human neuronal nitric oxide synthase: structure-activity studies and demonstration of in vivo activity.

Authors:  J L Collins; B G Shearer; J A Oplinger; S Lee; E P Garvey; M Salter; C Duffy; T C Burnette; E S Furfine
Journal:  J Med Chem       Date:  1998-07-16       Impact factor: 7.446

10.  Anchored plasticity opens doors for selective inhibitor design in nitric oxide synthase.

Authors:  Elsa D Garcin; Andrew S Arvai; Robin J Rosenfeld; Matt D Kroeger; Brian R Crane; Gunilla Andersson; Glen Andrews; Peter J Hamley; Philip R Mallinder; David J Nicholls; Stephen A St-Gallay; Alan C Tinker; Nigel P Gensmantel; Antonio Mete; David R Cheshire; Stephen Connolly; Dennis J Stuehr; Anders Aberg; Alan V Wallace; John A Tainer; Elizabeth D Getzoff
Journal:  Nat Chem Biol       Date:  2008-10-12       Impact factor: 15.040

View more
  4 in total

1.  NOpiates: Novel Dual Action Neuronal Nitric Oxide Synthase Inhibitors with μ-Opioid Agonist Activity.

Authors:  Paul Renton; Brenda Green; Shawn Maddaford; Suman Rakhit; John S Andrews
Journal:  ACS Med Chem Lett       Date:  2012-01-30       Impact factor: 4.345

Review 2.  Development of nitric oxide synthase inhibitors for neurodegeneration and neuropathic pain.

Authors:  Paramita Mukherjee; Maris A Cinelli; Soosung Kang; Richard B Silverman
Journal:  Chem Soc Rev       Date:  2014-10-07       Impact factor: 54.564

Review 3.  Recent advances toward improving the bioavailability of neuronal nitric oxide synthase inhibitors.

Authors:  He Huang; Richard B Silverman
Journal:  Curr Top Med Chem       Date:  2013       Impact factor: 3.295

4.  The discovery of potentially selective human neuronal nitric oxide synthase (nNOS) Inhibitors: a combination of pharmacophore modelling, CoMFA, virtual screening and molecular docking studies.

Authors:  Guanhong Xu; Yue Chen; Kun Shen; Xiuzhen Wang; Fei Li; Yan He
Journal:  Int J Mol Sci       Date:  2014-05-14       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.